Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iVu Imaging is a private U.S. medical device company focused on breast imaging. Its flagship product, SOFIA, is an automated 3D breast ultrasound system designed to provide rapid, compression-free supplemental imaging, particularly for women with dense breast tissue. The company markets SOFIA to radiologists, OB/GYN practices, and primary care settings as a workflow-friendly tool intended to improve earlier breast cancer detection. iVu Imaging received FDA 510(k) clearance for its SOFIA Automated Tomographic Ultrasound system and has pursued commercial distribution partnerships, including with Hitachi Aloka Medical. The business appears to be an active healthcare imaging company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iVu Imaging.